Literature DB >> 24363775

Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis.

Alok Agrawal1.   

Abstract

Entities:  

Year:  2008        PMID： 24363775      PMCID： PMC3869377          DOI： 10.2217/17460875.3.6.599

Source DB:  PubMed          Journal:  Future Lipidol        ISSN： 1746-0875


× No keyword cloud information.
  27 in total

1.  MooPoong (Gye Young Jeong) increases HDL-cholesterol but decreases LDL cholesterol and body-weight.

Authors:  Hwan-Suck Chung; Seung-Heon Hong; Keum-Rok Do; Hyung-Koo Rhee; Sung-Ki Jung; Woo-Jun Hwang; Hyung-Min Kim
Journal:  Immunopharmacol Immunotoxicol       Date:  2004-05       Impact factor: 2.730

2.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

3.  Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins.

Authors:  Claire Arnaud; Fabienne Burger; Sabine Steffens; Niels R Veillard; Tuan Huy Nguyen; Didier Trono; François Mach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-03-24       Impact factor: 8.311

4.  C-reactive protein binds to the 3beta-OH group of cholesterol in LDL particles.

Authors:  Sanna Taskinen; Marja Hyvönen; Petri T Kovanen; Seppo Meri; Markku O Pentikäinen
Journal:  Biochem Biophys Res Commun       Date:  2005-04-22       Impact factor: 3.575

5.  Lipids rich in phosphatidylethanolamine from natural gas-utilizing bacteria reduce plasma cholesterol and classes of phospholipids: a comparison with soybean oil.

Authors:  Hanne Müller; Lars I Hellgren; Elisabeth Olsen; Anders Skrede
Journal:  Lipids       Date:  2004-09       Impact factor: 1.880

Review 6.  What does minor elevation of C-reactive protein signify?

Authors:  Irving Kushner; Debra Rzewnicki; David Samols
Journal:  Am J Med       Date:  2006-02       Impact factor: 4.965

7.  C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids.

Authors:  Mi-Kyung Chang; Christoph J Binder; Michael Torzewski; Joseph L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

Review 8.  The connection between C-reactive protein and atherosclerosis.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; Bhavya Voleti; Alok Agrawal
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

9.  No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.

Authors:  Michael Torzewski; Kurt Reifenberg; Fei Cheng; Elena Wiese; Ines Küpper; Jeanine Crain; Karl J Lackner; Sucharit Bhakdi
Journal:  Thromb Haemost       Date:  2008-01       Impact factor: 5.249

10.  Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia.

Authors:  Alexander Kovacs; Per Tornvall; Roland Nilsson; Jesper Tegnér; Anders Hamsten; Johan Björkegren
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-16       Impact factor: 11.205
View more
  1 in total

1.  Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.

Authors:  Sanjay K Singh; Madathilparambil V Suresh; David J Hammond; Antonio E Rusiñol; Lawrence A Potempa; Alok Agrawal
Journal:  Clin Chim Acta       Date:  2009-06-21       Impact factor: 3.786
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.